Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

•Only 8% of ever-diagnosed HCV patients was lost to follow-up and eligible for retrieval.•Almost 30% of retrieved patients had signs of advanced fibrosis or cirrhosis.•Micro-elimination through retrieval is feasible and contributes to HCV elimination. The number of chronic hepatitis C virus (HCV)-in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of internal medicine 2022-07, Vol.101, p.93-97
Hauptverfasser: Isfordink, Cas J., van Dijk, Marleen, Brakenhoff, Sylvia M., Kracht, Patricia A.M., Arends, Joop E., de Knegt, Robert J., van der Valk, Marc, Drenth, Joost P.H., van den Berg, M., Honkoop, P., Abraham, S., Bosman, S., van Wijngaarden, P., Steenhuisen, K., Friederich, P., Dofferhoff, A.S. M., Berkhout, J., ter Borg, F., da Silva, J.M., Verhagen, M.A.M.T., Vos, X., Vlaar, K., Douma, R., Erkelen, W.G., den Reijer, M., Hoebe, C.J.P.A., Heil, J., Baven, M., van Soest, H., Korkmaz, K. Sebib, Bezemer, G., Lammers, A.J.J., Debast, S.B., de Jong, H.J.M., Bus, P., Sturm, P., den Hollander, J., Kampschreur, L.M., Venneman, N., Bosma, F., Koc, O.M., Ackens, R., van Oorschot, E., Klemt-Kropp, M., Baak, L.C., Brouwer, J.T., Spanier, B.W.M., Swanink, C., Blokzijl, H., Knoester, M., Liedorp, P., van Bergeijk, J., van Nunen, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Only 8% of ever-diagnosed HCV patients was lost to follow-up and eligible for retrieval.•Almost 30% of retrieved patients had signs of advanced fibrosis or cirrhosis.•Micro-elimination through retrieval is feasible and contributes to HCV elimination. The number of chronic hepatitis C virus (HCV)-infected patients who have been lost to follow-up (LTFU) is high and threatens HCV elimination. Micro-elimination focusing on the LTFU population is a promising strategy for low-endemic countries like the Netherlands (HCV prevalence 0.16%). We therefore initiated a nationwide retrieval project in the Netherlands targeting LTFU HCV patients. LTFU HCV-infected patients were identified using laboratory and patient records. Subsequently, the Municipal Personal Records database was queried to identify individuals eligible for retrieval, defined as being alive and with a known address in the Netherlands. These individuals were invited for re-evaluation. The primary endpoint was the number of patients successfully re-linked to care. Retrieval was implemented in 45 sites in the Netherlands. Of 20,183 ever-diagnosed patients, 13,198 (65%) were known to be cured or still in care and 1,537 (8%) were LTFU and eligible for retrieval. Contact was established with 888/1,537 (58%) invited individuals; 369 (24%) had received prior successful treatment elsewhere, 131 (9%) refused re-evaluation and 251 (16%) were referred for re-evaluation. Finally, 219 (14%) were re-evaluated, of whom 172 (79%) approved additional data collection. HCV-RNA was positive in 143/172 (83%), of whom 38/143 (27%) had advanced fibrosis or cirrhosis and 123/143 (86%) commenced antiviral treatment. Our nationwide micro-elimination strategy accurately mapped the ever-diagnosed HCV population in the Netherlands and indicates that 27% of LTFU HCV-infected patients re-linked to care have advanced fibrosis or cirrhosis. This emphasizes the potential value of systematic retrieval for HCV elimination.
ISSN:0953-6205
1879-0828
DOI:10.1016/j.ejim.2022.04.024